| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |